|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
In Talk on Personalized Medicine, Life Technologies’ CEO Explains Shift in Corporate Strategy
|
Bruce V. Bigelow |
10/26/10 |
San Diego
|
|
Sage Attracts Bigwigs, Hutch Adds Immunotherapy Center, the Pro-Life Vaccine Firm, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/07/10 |
Seattle
|
|
Necessity is the Mother of Stratification: Personalized Medicine is Getting Real
|
Don Rule |
09/30/10 |
Seattle
|
|
NextBio Finds Profit at Intersection Between Public and Private Genomic Data
|
Luke Timmerman |
09/28/10 |
San Francisco
|
|
Lee Hartwell, at 70, Tackles Personalized Medicine, Education in Latest Career Phase
|
Luke Timmerman |
09/20/10 |
Seattle
|
|
The Future of Humankind Depends on Quality Science Education
|
Lee Hartwell |
09/20/10 |
National
|
|
Nodality’s Personalized Medicine Recipe, Relypsa Pockets $70M, Big Oil Likes Seaweed Biofuel, & More Bay Area Life Sciences News
|
Luke Timmerman |
09/17/10 |
San Francisco
|
|
Nodality Nears Market With Technology to Get the Right Cancer Drug to the Right Patients
|
Luke Timmerman |
09/16/10 |
San Francisco
|
|
The Personalized Medicine Opportunity–Shifting the Business to Regulated Markets
|
Jim Prutow |
09/10/10 |
San Francisco
|
|
Protecting Consumers From Their Own Genetic Data Will Come at a Cost
|
Daniel MacArthur |
07/28/10 |
National
|
|
Seven Years Into Personalized Medicine Foray, Mohr Davidow Stays Patient, Keeps Betting on Big Idea
|
Luke Timmerman |
07/22/10 |
San Francisco
|
|
Theranos Raises $45M For Personalized Medicine
|
Luke Timmerman |
07/08/10 |
San Francisco
|
|
Leroy Hood’s Personalized Medicine Vision Enters Proving Ground at Ohio State
|
Luke Timmerman |
05/18/10 |
Seattle
|
|
How Can IT Tame the $2.5 Trillion Healthcare Beast? Xconomy Takes Close Look May 12
|
Luke Timmerman |
05/03/10 |
Seattle
|
|
Foundation Medicine Raises $25M to Get to the Bottom of Cancer Genomes
|
Ryan McBride |
04/14/10 |
Boston
|
|
ISB Nabs $6M Gift From VC
|
Luke Timmerman |
03/08/10 |
Seattle
|
|
Lantheus Medical Imaging Stakes Future on Innovation After Generic Hit to Key Product
|
Ryan McBride |
02/16/10 |
Boston
|
|
Why Biotech Innovators Are Beating a Path to Seattle
|
Chris Rivera |
02/12/10 |
Seattle
|
|
Former CombinatoRx CEO Alexis Borisy Lands at Third Rock Ventures, Launches New Startup
|
Ryan McBride |
02/11/10 |
Boston
|
|
Can Molecular Medicine Survive Its Teenage Years, and Reach its Potential This Decade?
|
Matthew O'Donnell |
01/15/10 |
Seattle
|
|
A Smarter War on Cancer
|
Tony Blau |
11/30/09 |
National
|
|
How NaviNet Built the Country’s Largest Healthcare Communications Network
|
Ryan McBride |
08/17/09 |
Boston
|
|
Seattle Genetics Recruits at Warp Speed, Amgen Passes Cancer Test, Stephen Friend’s Adventure & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/13/09 |
Seattle
|
|
Immuneering, Led by Young CEO and Mentor, Aims to Pick Which Cancer Drugs Should Work
|
Luke Timmerman |
07/07/09 |
Boston
|
|
Personalized Medicine—A Tall Mountain
|
Victor McElheny |
05/11/09 |
Boston
|
|
Era of Over-the-Counter DNA Diagnostic Test Arrives in San Diego
|
Juha-Pekka Tikka |
04/30/09 |
San Diego
|
|
Healthcare Leaders Lay Groundwork for Wave of Innovation in Medical Information Technologies
|
Bruce V. Bigelow |
03/31/09 |
San Diego
|
|
Amgen Tries to “Personalize” Drug, VLST Snags Deal, Tobacco Money Backs Research, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
12/18/08 |
Seattle
|
|
Amgen Cancer Drug Getting Personal, Which May Be a Good Thing for Patients—and Sales
|
Luke Timmerman |
12/15/08 |
Seattle
|
|
Innovation Will Set America Back on Track
|
Robert Nelsen |
12/04/08 |
National
|
|
Page 2 of
3 |
« previous page · next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.